ERIS Lifesciences Ltd share price logo

ERIS Lifesciences Ltd Share Price

NSE: ERIS

BSE: 540596

Small Cap

Healthcare Sector

₹1572.20

-18.40

(-1.16%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

ERIS Lifesciences Ltd Stock Performance

as on December 12, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,564.5
    ₹1,597.9
    downward going graph

    0.49%

    Downside

    1.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,097.2
    ₹1,910
    downward going graph

    30.21%

    Downside

    21.49%

    Upside

    downward going graph

ERIS Lifesciences Ltd share price movements today

Previous Close
₹1,590.60
Open
₹1,590.80
Volume
92.56K
Upper Circuit
₹1,908.70
Lower Circuit
₹1,272.50
Day's Low - High
₹1,564.5 - ₹1,597.9
52 Week Low - High
₹1,097.2 - ₹1,910

ERIS Lifesciences Ltd Historical Returns

1 Month Return
+ 3.56 %
3 Month Return
-6.08 %
1 Year Return
+ 7.32 %
3 Year Return
+ 138.21 %
5 Year Return
+ 192.31 %

ERIS Lifesciences Ltd Fundamentals

as on December 12, 2025 at 4:01 pm IST

Market Cap

₹21,416.02 Cr

Return on Equity (ROE)

3.07

PE Ratio (TTM)

51.48

Return on capital employed (ROCE)

6.83

Industry PE ratio

41.92

Beta (LTM)

0.41

P/B Ratio

7.67

Dividend Yield

0.52

PEG Ratio

10.44

Quarterly Earnings Growth YOY

39.56

EPS (TTM)

27.51

Sector

Pharmaceuticals

Book Value

209.57

Technical Analysis

Bearish

View Technical Analysis

ERIS Lifesciences Ltd Stock Valuation

as on December 12, 2025 at 4:01 pm IST

ERIS Lifesciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (16.77x)

September 9, 2019

Industry (41.92x)

December 12, 2025

Today (51.48x)

December 12, 2025

Highest (71.34x)

June 16, 2025

LowHigh

Today’s Price to Earnings Ratio: 51.48x

ERIS Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ERIS Lifesciences Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
ERIS Lifesciences Ltd image
ERIS Lifesciences Ltd
BUY21,416.0238.46%0.763742,908
Phaarmasia Ltd image
Phaarmasia Ltd
NA63.2351.48%0.00-224
Sanofi Consumer Healthcare India Ltd image
Sanofi Consumer Healthcare India Ltd
BUY10,633.70-1.17%0.00181724
Gujarat Terce Laboratories Ltd image
Gujarat Terce Laboratories Ltd
NA33.09102%0.00-150
Innova Captab Ltd image
Innova Captab Ltd
BUY4,128.216.65%0.631281,243
See all

Analyst Recommendation on ERIS Lifesciences Ltd Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for ERIS Lifesciences Ltd. Average target price of ₹1789.1

Source: S&P Global Market Intelligence

ERIS Lifesciences Ltd Share Price Target

Get share price movements and forecasts by analysts on ERIS Lifesciences Ltd.

What analysts predicted

13.8%UPSIDE

Target Price

₹1789.1

Current Price

₹1572.2

Analyzed by

10 Analysts

High

₹1940

Target

₹1789.10

Low

₹1530

ERIS Lifesciences Ltd target price ₹1789.1, a slight upside of 13.8% compared to current price of ₹1572.2. According to 10 analysts rating.

Source: S&P Global Market Intelligence

ERIS Lifesciences Ltd Stock’s Investor Sentiment and Interest

Investment in ERIS Lifesciences Ltd Shares on INDmoney has grown by 725.00% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:725.00% versus previous 30 day period

Search interest for ERIS Lifesciences Ltd Stock has increased by 332% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:332% versus previous 30 day period

ERIS Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
417.84
396.59
460.03
500.52
483.48
547.27
715.59
738.95
722.12
702.6
771.56
790.15
Other Income
2.24
1
0.99
3.48
4.2
15.15
1.64
4.55
4.22
8.01
3.58
3.09
Total Income
425.5
403.8
467.61
508.78
490.5
566.08
721.36
745.72
731.67
713.31
776.58
795.5
Expenses
286.06
283.9
296.87
324.16
310.79
402.5
469.73
476.66
477.14
452.91
496.29
504.2
Operating Profit
131.78
112.69
163.16
176.36
172.69
144.77
245.86
262.29
244.98
249.69
275.27
285.95
Operating Profit Margin %
31.54%
28.41%
35.47%
35.24%
35.72%
26.45%
34.36%
35.49%
33.93%
35.54%
35.68%
36.19%
Profit Before Interest, Tax and Depreciation
139.44
119.9
170.74
184.63
179.71
163.58
251.63
269.06
254.53
260.4
280.29
291.3
Interest
3
8.87
17.36
16.3
18.12
33.03
60.37
59.47
57.17
54.28
48.68
49.55
Depreciation
29.9
35.13
40.89
42.09
45.72
53.8
75.74
80.48
81
77.25
70.51
69.08
Profit Before Tax
106.54
75.9
112.49
126.24
115.87
76.75
115.52
129.11
116.36
128.87
161.1
172.67
Tax Paid
6.3
14.42
18.84
3.93
14.41
-2.95
25.97
32.76
29.3
26.52
36
38.2
Profit After Tax
100.23
61.48
93.65
122.31
101.46
79.7
89.55
96.35
87.06
102.35
125.1
134.47
Total Net profit including share of profit / Loss from associate company
100.23
61.48
93.65
122.31
101.46
79.7
89.55
96.35
87.06
102.35
125.1
134.47
EPS
7.49
4.81
6.97
9.08
7.55
5.22
6.11
6.73
6.16
6.9
8.66
8.82
Actual EPS
7.49
4.81
6.97
9.08
7.55
5.22
6.11
6.73
6.16
6.9
8.66
8.82
Adjusted EPS
7.49
4.81
6.97
9.08
7.55
5.22
6.11
6.73
6.16
6.9
8.66
8.82
Diluted EPS
7.49
4.79
6.97
9.06
7.54
5.21
6.1
6.72
6.15
6.89
8.64
8.81

ERIS Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
749.5
827.1
967.2
1,058.18
1,192.64
1,326.17
1,661.82
1,991.3
2,879.26
Other Income
25.11
26.41
31.69
15.4
8.71
26.09
11.15
23.82
18.42
Total Income
774.61
882.01
1,013.86
1,089.46
1,220.57
1,373.14
1,696.3
2,032.97
2,912.06
Expenses
480.43
533.59
637.25
705.69
781.29
862.09
1,148.4
1,334.32
1,876.44
Operating Profit
269.07
293.51
329.95
352.49
411.35
464.08
513.42
656.98
1,002.82
Operating Profit Margin %
35.9%
35.49%
34.11%
33.31%
34.49%
34.99%
30.9%
32.99%
34.83%
Profit Before Interest, Tax and Depreciation
294.18
348.42
376.61
383.77
439.28
511.05
547.9
698.65
1,035.62
Interest
1.03
10.55
22.9
2.16
1.8
4.15
26.17
84.8
231.29
Depreciation
22.76
25.64
36.35
50.26
42.99
64.71
117.09
182.51
315.46
Profit Before Tax
270.39
312.23
317.36
331.35
394.49
442.19
404.64
431.34
488.87
Tax Paid
23.78
17.25
26.21
34.85
39.36
36.4
30.48
34.22
114.2
Profit After Tax
246.61
294.98
291.15
296.51
355.14
405.79
374.16
397.12
374.67
Total Net profit including share of profit / Loss from associate company
246.61
294.98
291.15
296.51
355.14
405.79
374.16
397.12
374.67
EPS
17.95
21.39
21.15
21.61
26.16
29.89
28.1
28.82
25.85
Actual EPS
17.95
21.39
21.15
21.61
26.16
29.89
28.1
28.82
25.85
Adjusted EPS
17.95
21.39
21.15
21.61
26.16
29.89
28.1
28.82
25.85
Diluted EPS
17.95
21.39
21.13
21.59
26.14
29.88
28.07
28.79
25.81

ERIS Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
131.48
200.21
234.64
223
271.17
375.36
378.26
291.74
486.01
1,065.01
Cash Flow from Investing Activities
-43.91
-184.45
-590.1
-12.7
123.23
-323.36
-319.6
-974.61
-1,827.66
-78.2
Cash Flow from Financing Activities
-83.7
-23.66
363.21
-221.05
-334.6
-82.4
-45.15
688.04
1,379.78
-881.32
Net Cash Flow
3.87
-7.91
7.75
-3.11
59.81
-30.39
13.96
5.15
38.13
105.49

Mutual Funds that own ERIS Lifesciences Ltd Stock

Check out the Mutual Funds with significant holdings in ERIS Lifesciences Ltd.

ERIS Lifesciences Ltd Corporate Actions

View detailed summary of the earnings and dividend history of ERIS Lifesciences Ltd.

  • ERIS Lifesciences Ltd Earnings Results

    ERIS Lifesciences Ltd’s net profit jumped 31.23% since last year same period to ₹120.19Cr in the Q2 2025-2026. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 1.86% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • ERIS Lifesciences Ltd Dividends February,2025

    In the quarter ending December 2024, ERIS Lifesciences Ltd has declared dividend of ₹7.35 per share on 07 Feb 2025 - translating a dividend yield of 0.47%.

    Read More about Dividends

Indices Featuring ERIS Lifesciences Ltd Stock

Check stock indices that include ERIS Lifesciences Ltd.

Nifty Smallcap 250

₹16,396.85

0.83 (▲135.5%)

S&P BSE 400 MidSmallCap

₹12,058.26

1.01 (▲120.08%)

BSE 500

₹37,228.82

0.72 (▲265.72%)

BSE Healthcare

₹44,085.92

0.19 (▲84.41%)

S&P BSE 250 SmallCap

₹6,611.62

0.75 (▲49.32%)

Nifty MidSmallcap 400

₹20,023.65

1.06 (▲210.7%)

BSE Small-Cap

₹50,890.67

0.65 (▲327.34%)

Nifty 500

₹23,726.20

0.74 (▲175.35%)

Insights on ERIS Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 713.31 Cr → 795.5 Cr (in ₹), with an average increase of 5.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ERIS stock has moved up by 3.6%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 16.78% to 17.33% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ERIS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 83.76 Cr → 120.19 Cr (in ₹), with an average increase of 11.0% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 54.84% to 54.85% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 13.3% return, outperforming this stock by 6.0%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.40% to 7.21% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 18.59% to 18.57% in Sep 2025 quarter

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated in 2007 and is engaged in manufacturing, distributing and marketing of branded pharmaceutical products, having presence in high growth chronic, sub-chronic and acute therapeutic areas. It has a portfolio of 112 Mother Brands across therapy areas and 5 subsidiaries, 4 of which are wholly owned subsidiaries. The company has made two acquisitions - UTH Healthcare Ltd for Rs 129 million for its product portfolio in 2017 and Indian branded formulations business Strides for Rs 5000 crore in 2017. It made its debut in secondary equity market in 2017 and in FY 2018 capital expenditure amounted to Rs 242.69 million and Rs 5061.52 million was paid towards business acquisition. In FY 2019 the company expanded its operations by constructing new softgel facility, extended facility for supplements and nutraceuticals, and added Zomelis products in its portfolio. In 2020, Kinedex became wholly owned subsidiary and the company launched new business divisions. In FY21 it launched Gluxit in SGLT2 segment, Eritel and LNBloc maintained ranks in their respective segments, developed Bricet and fortified portfolio with the launch of ZACD. In FY22 it acquired 100 stake in Oaknet Healthcare Ltd worth Rs 6500 million and launched human insulin through its subsidiary Eris M.J. Biopharm Ltd and Xsulin in vials and cartridges.

Revenue: ₹790.15Cr as on September 2025 (Q2 FY26)
Net Profit: ₹134.47Cr as on September 2025 (Q2 FY26)
Listing date: 29 Jun, 2017
Chairperson Name: Amit Indubhushan Bakshi
OrganisationERIS Lifesciences Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOAmit Indubhushan Bakshi
E-voting on sharesClick here to vote

FAQs

What is ERIS Lifesciences Ltd share price today?

ERIS Lifesciences Ltd share price today stands at ₹1572.2 as on at the close of the market. ERIS Lifesciences Ltd share today touched a day high of ₹1597.9 and a low of ₹1564.5.

What is the 52 week high and 52 week low range for ERIS Lifesciences Ltd share?

ERIS Lifesciences Ltd touched a 52 week high of ₹1910 and a 52 week low of ₹1097.2. ERIS Lifesciences Ltd share price today i.e. is closed at ₹1572.2, which is -17.69% down from its 52 week high and 43.29% up from its 52 week low.

What is ERIS Lifesciences Ltd's market capitalisation today?

ERIS Lifesciences Ltd market capitalisation is ₹21,416.02 Cr as on .

How to buy ERIS Lifesciences Ltd shares?

To buy ERIS Lifesciences Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ERIS or ERIS Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in ERIS Lifesciences Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is ERIS Lifesciences Ltd trading volume today?

ERIS Lifesciences Ltd trading volume is 92.56K as on . This means that 92.56K shares of ERIS Lifesciences Ltd were bought and sold on the stock market during today's trading session.